Reciprocal relationship from TOVX graph: prescribe legally available drugs for off-label uses, drugs may be marketed only for the approved indications and in accordance with the provisions of the app…
Calidi Biotherapeutics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
CLDWW-DEBT-8676
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2024-12-31.
CLDWW-DEBT-8675
Warrants outstanding: 5026613
90%
xbrl warrant detail from xbrl 2025-09-30.
Calidi Biotherapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Calidi Biotherapeutics, Inc..
Calidi Biotherapeutics, Inc. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for Calidi Biotherapeutics, Inc..
Calidi Biotherapeutics, Inc. Extended Supply Chain Network